|Bid||0.1400 x 0|
|Ask||0.1450 x 0|
|Day's Range||0.1450 - 0.1500|
|52 Week Range||0.0250 - 0.3500|
|Beta (5Y Monthly)||2.37|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
VANCOUVER, BC / ACCESSWIRE / January 29, 2021/ NeutriSci International Inc. ("NeutriSci" or the "Company") (TSXV:NU)(OTCQB:NRXCF)(FRANKFURT:1N9), an innovative technology company developing products for the nutraceutical industry, is pleased to announce that it has closed a non-brokered private placement (the "Placement") in which it raised gross proceeds of $370,050.
* long-term growth strategy for second-largest medical cannabis market in Asia * we anticipate further orders based upon our initial market interest VANCOUVER, BC / ACCESSWIRE / January 18, 2021 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9), an innovative technology company developing products for the nutraceutical industry, is very pleased to announce the details regarding its first large order for the TABLETZ brand in Japan.
VANCOUVER, BC / ACCESSWIRE / December 14, 2020 / NeutriSci International Inc.